This same active ingredient is also found in another medication, Wegovy, which is specifically approved for weight management
TOUR-QUALITY FEEL
Sanjeev Sockalingam, Scientific Director, framed the approval as a regulatory milestone that should "prompt governments, insurers, and employers to reconsider how obesity treatment is covered within these systems," noting that "fewer than 20 per cent of Canadians with private drug benefit plans have access to Health Canada-approved obesity treatment medications" [Source: obesitycanada.ca/news/health-canada-generic-semaglutide-approval/]

[1] [2] 25 mg Speed of titration : Patients who increase their dose too rapidly or skip the recommended titration schedule experience more severe symptoms Individual susceptibility : Some patients are more prone to gastrointestinal side effects due to pre-existing conditions such as gastroparesis or functional dyspepsia Dietary habits : Consuming large, high-fat meals whilst on Ozempic can exacerbate nausea and vomiting Most patients who experience vomiting find that symptoms are most troublesome during the first 4-8 weeks of treatment or following dose escalation
Increased risk of pancreatic disease: Another risk associated with semaglutide is the potential for an increased risk of biliary disease, such as cholelithiasis (gallstones) [14, 15]
"Vision care is another popular oneprescription glasses, contacts, and exams all qualify